Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.

Article date: 1990/1/1

PubMed ID: 1980019

Journal name: Progress in brain research (ISSN: 0079-6123)


This document is available from: http://directlinks.cc/files/muscimol/1980019.pdf

Author List: Haroutunian V, Santucci A C, Davis K L

Publication Types: Journal Article

Substances mentioned in the article: Hydroxydopamines; Ibotenic Acid; Serotonin; Somatostatin; Cysteamine; Oxidopamine; Corticotropin-Releasing Hormone; Physostigmine; Choline O-Acetyltransferase; Acetylcholinesterase; Dopamine; Norepinephrine;

Mesh terms: Acetylcholinesterase/metabolism; Alzheimer Disease/chemically induced; Animals; Avoidance Learning/drug effects; Cerebral Cortex/drug effects; Choline O-Acetyltransferase/metabolism; Corticotropin-Releasing Hormone/metabolism; Cysteamine/pharmacology; Disease Models, Animal; Dopamine/metabolism; Hydroxydopamines; Ibotenic Acid; Male; Norepinephrine/metabolism; Oxidopamine; Physostigmine/pharmacology; Rats; Rats, Inbred Strains; Reference Values; Serotonin/metabolism; Somatostatin/metabolism;

1980019.txt ยท Last modified: 2018/11/22 21:16 (external edit)